04:08 PM EDT, 10/14/2025 (MT Newswires) -- William D. Waddill, Director, on October 10, 2025, sold 12,000 shares in Protagonist Therapeutics ( PTGX ) for $979,480. Following the Form 4 filing with the SEC, Waddill has control over a total of 5,130 common shares of the company, with 5,130 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1377121/000110465925099252/xslF345X05/tm2528674-1_4seq1.xml